FindTrial
Sign In

Continuous infusion versus bolus infusion of clotting factor following total knee arthroplasty in patients with haemophilia

Continuous infusion versus bolus infusion of clotting factor following total knee arthroplasty in patients with haemophilia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002404
Enrollment
36
Registered
2017-08-04
Start date
2014-05-30
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Hosipital at Gangdong
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: The inclusion criteria were severe hemophilia A (FVIII: C < 1%), more than 150 exposure days (EDs) to any FVIII product before enrolment, and good compliance.

Exclusion criteria

Exclusion criteria: Patients with previous history of inhibitors were excluded.

Design outcomes

Primary

MeasureTime frame
To evaluate postoperative blood loss, the volume of drained blood was assessed from patient records.—

Secondary

MeasureTime frame
A surgery-related decrease in hemoglobin was observed in both groups.—

Countries

Korea, Republic of

Contacts

Public ContactYoung Shil Park

Kyung Hee University Hosipital at Gangdong

pysmd@khnmc.or.kr+82-2-440-6133

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 26, 2026